Statement of Organization, Functions, and Delegations of Authority, 5442-5444 [2016-01833]

Agencies

[Federal Register Volume 81, Number 21 (Tuesday, February 2, 2016)]
[Notices]
[Pages 5442-5444]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-01833]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Statement of Organization, Functions, and Delegations of 
Authority

    Part C (Centers for Disease Control and Prevention) of the 
Statement of Organization, Functions, and Delegations of Authority of 
the Department of Health and Human Services (45 FR 67772-76, dated 
October 14, 1980, and corrected at 45 FR 69296, October 20, 1980, as 
amended most recently at 81 FR 4912-4913, dated January 28, 2016) is 
amended to reflect the reorganization of the National Center on Birth 
Defects and Developmental Disabilities, Centers for Disease Control and 
Prevention.
    Section C-B, Organization and Functions, is hereby amended as 
follows:
    Delete in its entirety the title and function statements for the 
Division of Birth Defects and Developmental Disabilities (CUBB) and 
insert the following:
    Division of Congenital and Developmental Disorders (CUBB). (1) 
Conducts research to determine the causes and prevention of birth 
defects and developmental disabilities; (2) maintains and expands 
support for state-based surveillance; (3) evaluates the effectiveness 
of efforts to prevent birth defects and developmental disabilities; (4) 
conducts and disseminates findings of epidemiologic research, 
investigations, demonstrations, and programs directed toward the 
prevention of selected adverse reproductive outcomes that are 
environmentally related; (5) provides assistance to State and local 
health departments on community exposures to terotogenic, mutagenic, 
embryotoxic, other environmental agents, and genetic influences 
adversely interfering with normal growth and development; (6) conducts 
research and develops programs to identify women at high risk of an 
alcohol-exposed pregnancy and to fund epidemiologic and clinical 
research studies aimed at early identification and intervention of 
children affected by prenatal alcohol exposure; (7) works closely with 
international organizations and entities in developing strategies and 
programs for reducing the number of birth defects and developmental 
disabilities; (8) develops and evaluates prevention strategies and 
provides training, technical consultation, and assistance to States and 
localities in developing their

[[Page 5443]]

capacity for planning, establishing, and maintaining surveillance and 
prevention programs; (9) maintains and oversees funding and technical 
assistance to state-based institutions (e.g., the Centers for Birth 
Defects Research and Prevention that seek causes and promotes 
prevention of birth defects); (10) plans, develops, establishes, and 
maintains systems of surveillance including registries for monitoring, 
evaluating and disseminating information; (11) assists in increasing 
the capacity of States to prevent and control birth defects and 
developmental disabilities through training, technology transfer, 
grants, cooperative agreements, contracts, and other means; (12) 
provides information and education to the public; (13) provides 
services, consultation, technical assistance, and information to 
States, localities, other Federal agencies, international 
organizations, and other public and private organizations; (14) 
provides training in the epidemiology to professionals throughout the 
U.S. and abroad; and (15) collaborates and coordinates activities with 
other CIOs and HHS agencies.
    Office of the Director (CUBB1). (1) Manages, directs, and 
coordinates the research agenda and activities of the division; (2) 
provides leadership and guidance on strategic planning, policy, program 
and project priority planning and setting, program management, and 
operations; (3) establishes division goals, objectives, and priorities; 
(4) monitors progress in implementation of projects and achievement of 
objectives; (5) plans, allocates, and monitors resources; (6) provides 
management, administrative, and support services, and coordinates with 
appropriate NCBDDD offices on program and administrative matters; (7) 
provides liaison with other CDC organizations, other governmental 
agencies, international organizations, and other outside groups; (8) 
provides support for internal scientific advisory groups; (9) provides 
scientific leadership and guidance to the division to assure highest 
scientific quality and professional standards; and (10) provides 
coordinative support for CDC's efforts to reduce adverse consequences 
from birth defects, developmental disabilities, and pediatric genetic 
conditions.
    Birth Defects Branch (CUBBB). (1) Designs and conducts 
epidemiologic and genetic research to identify causes and risk factors 
of birth defects; (2) conducts and evaluates interventions to improve 
infant and child health by preventing or reducing the adverse 
consequences of birth defects; (3) designs and conducts surveillance of 
selected birth defects to identify rates, trends, and patterns of 
occurrence, and to evaluate the effectiveness of prevention programs; 
(4) disseminates findings of studies to the scientific and public 
health communities, and to the general public; (5) provides technical 
assistance to state and local agencies on surveillance of birth 
defects, epidemiologic research, prevention program design and 
evaluation, and prevention effectiveness research; (6) funds and 
coordinates grant and cooperative agreement programs and other 
extramural activities to improve the knowledge base for the prevention 
of birth defects through surveillance, epidemiologic research, and 
applies research of preventive interventions; (7) coordinates 
activities with other CDC functional units, HHS, other federal 
agencies, and appropriate private organizations regarding research and 
prevention programs for birth defects; (8) works with international 
organizations in developing strategies for the prevention of birth 
defects; and (9) disseminates findings of research through direct 
contact with health authorities, publication and distribution of 
special reports, publication in scientific and technical journals, 
conference presentations, and other appropriate means.
    Prevention Research and Translation Branch (CUBBC). (1) Modifies 
the impact of prenatal exposures leading to adverse physical and 
developmental impairments in infants, children, and adults including 
integrating successful prevention programs into social and medical 
environments, and evaluating innovative, effective, and strategic 
health promotion programs; (2) develops, implements, evaluates, and 
disseminates education and communication interventions that lead to the 
prevention of birth defects and developmental disabilities; (3) designs 
and conducts surveillance of preventable birth defects and 
developmental disabilities to identify rates, trends, and patterns of 
occurrence, and to evaluate the effectiveness of prevention programs; 
(4) disseminates findings of epidemiologic studies to the scientific 
and public health communities, and to the general public; (5) conducts 
prevention effectiveness research to evaluate interventions strategies 
for the prevention of birth defects and developmental disabilities; (6) 
identifies and monitors major preconception, prenatal and perinatal 
risks, and protective factors for fetal alcohol spectrum disorders 
(FASD) and other prenatal alcohol attributable conditions; (7) provides 
technical assistance to state and local agencies on surveillance, 
epidemiologic research, prevention program design and evaluation, and 
prevention effectiveness research; (8) funds and coordinates grant and 
cooperative agreement programs and other extramural activities to 
improve the knowledge base for the prevention of birth defects and 
developmental disabilities through surveillance, epidemiologic 
research, and applies research of preventive interventions; (9) 
coordinates activities with other CDC functional units, HHS, other 
federal agencies and appropriate private organizations regarding 
research and prevention programs for birth defects and developmental 
disabilities; (10) works with international organizations in developing 
strategies for the prevention of birth defects and developmental 
disabilities; and (11) disseminates finding of research through direct 
contact with health authorities, publication and distribution of 
special reports, publication in scientific and technical journals, 
conference presentations, and other appropriate means.
    Developmental Disabilities Branch (CUBBD). (1) Designs and conducts 
surveillance of developmental disabilities to identify rates, trends, 
and patterns of occurrence, and to evaluate the effectiveness of 
prevention programs; (2) conducts epidemiologic studies of 
developmental disabilities to identify causes and risk factors for 
these conditions; (3) disseminates findings of epidemiologic studies to 
the scientific and public health communities and to the general public; 
(4) conducts prevention effectiveness research to evaluate 
interventions strategies for the prevention of developmental 
disabilities; (5) conducts epidemiologic studies to identify and 
describe specific conditions and long-term outcomes of developmental 
disabilities; (6) provides technical assistance to state and local 
agencies on surveillance of developmental disabilities, epidemiologic 
research, prevention program design and evaluation, and prevention 
effectiveness research; (7) funds and coordinates grant and cooperative 
agreement programs and other extramural activities to improve the 
knowledge base for the prevention of developmental disabilities through 
surveillance, epidemiologic research, and applies research of 
preventive interventions; (8) coordinates activities with other CDC 
functional units, HHS, other federal agencies and appropriate private 
organizations regarding research and prevention programs for

[[Page 5444]]

developmental disabilities; (9) collaborates with international 
organizations in developing strategies for the prevention of 
developmental disabilities; (10) disseminates findings of research 
through direct contact with health authorities, publication and 
distribution of special reports, publication in scientific and 
technical journals, conference presentations, and other appropriate 
means; and (11) provides training in the epidemiology of developmental 
disabilities to professionals throughout the United States and abroad.
    Delete in its entirety the title and function statement for the 
Epidemiology and Surveillance Branch (CUBDB) and insert the following:
    Epidemiology and Surveillance Branch (CUBDB). (1) Provides 
scientific leadership in the design and implementation of monitoring 
systems as well as designs and conducts epidemiologic and genetic 
research to identify causes, risk factors and complications of blood 
disorders in affected populations; (2) designs and manages surveillance 
systems to evaluate the incidence, morbidity, and mortality associated 
with blood diseases and disorders; (3) plans, develops and coordinates 
special surveys and populations studies to monitor and assess the 
complications of blood disorders; (4) designs and implements studies 
using surveillance data to identify risk factors for the complications 
of blood disorders, and evaluating the effectiveness of the prevention 
activities; (5) provides epidemiologic and medical consultation and 
technical assistance, including epidemic aids to state and local health 
departments, other governmental agencies, and other public and private 
institutions in the investigation of blood disorders and related 
complications; (6) designing and implements studies to evaluate the 
effectiveness of implemented prevention strategies in the treatment 
centers, (7) works closely with internal and external organizations in 
applying prevalence and incidence data to target and evaluate programs 
to prevent the complications of blood diseases and chronic hereditary 
disorders, (8) publishes findings and advances arising out of 
surveillance and epidemiologic research to the scientific and public 
health communities; (9) provides training services to states, 
localities, and other countries in investigation, diagnosis, 
prevention, and control of blood diseases and chronic hereditary 
disorders; (10) assists in designing, implementing, and evaluating 
prevention and counseling programs for persons and their families with 
chronic blood diseases and selected chronic hereditary disorders; (11) 
designs, implements and coordinates the prevention and surveillance 
activities of specialized federally funded prevention centers organized 
to prevent the complications of blood diseases and chronic hereditary 
disorders; (12) conducts and supports both qualitative and quantitative 
research to expand the knowledge base related to blood disorders across 
the lifespan; (13) collaborates with hemostasis laboratory branch and 
incorporates the findings of these branches' activities which leads to 
prevention of complications of blood disorders; (14) supports public 
health analysis to include facilitating data collection, data 
management, data manipulation, analysis, project reporting and 
presentation; and (15) conducts applied research to develop, evaluate, 
improve and standardize public information systems and educational 
modules which support the prevention of complications from blood 
disorders.
    Delete in its entirety the title and function statement for the 
Laboratory Research Branch (CUBDC) and insert the following:
    Hemostasis Laboratory Branch (CUBDC). (1) Identifies new genetic 
markers of risk factors and clotting defects for affected groups; (2) 
provides reference laboratory diagnosis for multi-site epidemiologic 
and surveillance studies; (3) develops techniques and interpretation 
methods to improve molecular and coagulation diagnosis; (4) provides 
diagnostic support for epidemiologic studies and epidemic aids on 
emerging blood disorders and chronic hereditary disorders; (5) 
determines the mechanisms of pathogenesis and complications of blood 
disorders and chronic hereditary disorders;
    (6) conducts research and providing reference services on 
diagnostic techniques for blood disorders and chronic hereditary 
disorders; (7) conducts research to improve laboratory methodologies 
and materials; (8) where appropriate, maintains the national reference 
laboratory for blood disorders and chronic hereditary disorders; (9) 
works closely with entities and organizations within the agency and 
organizations external to the agency to provide laboratory services in 
support of projects whose primary aim is to prevent and reduce 
complications associated with blood disorders and chronic hereditary 
disorders; and (10) publishes findings and advances arising out of 
surveillance and epidemiologic research to the scientific and public 
health communities.
    Delete in its entirety the title and function statement for the 
Prevention Research and Informatics Branch (CUBDD).

Sherri A. Berger,
Chief Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2016-01833 Filed 2-1-16; 8:45 am]
 BILLING CODE 4160-18-P